Hutch News
Results per Page:
Holland receives NCI Outstanding Investigator Award
Neuroscientist will tackle genetic abnormalities that drive cancers and could be therapeutic targets
New research uncovers how common genetic mutation drives cancer
Findings in Nature show that targeted therapy for mutated gene can slow or prevent tumor growth in many kinds of cancer
Good News: Dr. Jeff Whiteaker wins NCI Research Specialist Award; Human Biology gains four new faculty members
Celebrating faculty and staff achievements
Inherited mutations tied to advanced prostate cancer
Genetic screening could help men with prostate cancer find better treatments — and alert family members to their own cancer risk
Study sheds new light on molecular pathways behind marrow disorders
How a single alteration in fundamental cellular machinery drives blood diseases and cancers
Seattle researchers map genome of advanced, lethal prostate cancers and discover 'hypermutations'
First comprehensive assessment of DNA errors that drive advanced prostate cancer
Muscular dystrophy: zeroing in on a cause
Tapscott, Snider and global research team further understanding of key genetic mutation, reveal possible drug targets
Gene mutation boosts breast cancer risk contralaterally
PHS findings on BRCA mutations underscore importance of genetic testing in younger patients
Funds for lung cancer biomarker research
Mouth-cell test holds promise for weighing lung cancer risk
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
Mechanism of cisplatin resistance 'unlike any previously identified'
New study provides a clearer picture of breast-cancer gene mutations in American women
Findings shed new light on mutation risk in older and African-American women